Aims Obesity is a chronic and recurrent disease. In the past few years, Endoscopic sleeve gastroplasty (ESG) has emerged as a minimally invasive technique to fill the therapeutic gap between medical and surgical approaches to obesity. ESG consists of full-thickness suturing of the gastric body aimed at restricting gastric volume and impairing gastric motility. Most of the published data on ESG show the results of the procedure in the first 12-24 months. In this study, we aim to report long-term results of ESG to implement the evidence of long-term effectiveness further.
No takes yet. Share an insight, caveat, or question.
Matteo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: